ARUP's Laboratory Test Directory

ARUP's Laboratory Test Directory contains complete, up-to-date test information, including methodology and reporting times, collection and transportation specifications, reference intervals, test notes, and CPT codes. Clients can access entries via an A to Z index and search by test name, key word, test number, or mnemonic.

Wildcard Searching

The * wildcard is used to search for many letters within a word and can be used when the spelling, suffix, or prefix of the search term are in question: e.g., manage* = management, manages, managed, manager, etc.; d*ing = divorcing, dividing, droning, etc.

The ? wildcard is used to search for a single letter within a word and can be used when the spelling of the search term is in question: e.g., h?t = hat, hit, hot, etc. (but will NOT find heat).

Search the Lab Test Directory

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ALLERGENS

Lab Focus

  • New LTD

    Upcoming Laboratory Test Directory Changes

    We have received your feedback and are updating the new LTD to make it even better!
    Find out more.
  • Switch to Order Management Today!

    Switch to Order Management for a More Efficient Workflow

    This web-based application is conveniently located within ARUP Connect and is available to all clients.
    Find out more.

  • Product Recall

    Recall of BD Vacutainer 2.7mL Plus Citrate Blood Collection Tube. ARUP clients should send coagulation specimens in the ARUP STT; lot number will not be available to ARUP personnel.
    Download recall notice from BD Diagnostics.

  • New Test Available: 2007132, BRAF V600E Mutation Detection in Hairy Cell Leukemia by Real-Time PCR, Quantitative

    For quantitation of the BRAF V600E mutation in blood and bone marrow for diagnosis and ongoing therapeutic monitoring of patients with hairy cell leukemia.
    Read more.

  • New and Improved Testing for Leukemia/Lymphoma Phenotyping

    Beginning May 20, 2013, ARUP will change the way many of the tests currently offered for leukemia/lymphoma phenotyping are handled and reported. These changes will allow ARUP to better tailor testing for each patient. They will also allow greater flexibility in performing and billing for individual markers.
    Read more.